288 related articles for article (PubMed ID: 20005186)
1. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
Gromov P; Gromova I; Bunkenborg J; Cabezon T; Moreira JM; Timmermans-Wielenga V; Roepstorff P; Rank F; Celis JE
Mol Oncol; 2010 Feb; 4(1):65-89. PubMed ID: 20005186
[TBL] [Abstract][Full Text] [Related]
2. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I
Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989
[TBL] [Abstract][Full Text] [Related]
3. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
4. Proteomic Profiling of Paired Interstitial Fluids Reveals Dysregulated Pathways and Salivary NID1 as a Biomarker of Oral Cavity Squamous Cell Carcinoma.
Hsu CW; Chang KP; Huang Y; Liu HP; Hsueh PC; Gu PW; Yen WC; Wu CC
Mol Cell Proteomics; 2019 Oct; 18(10):1939-1949. PubMed ID: 31315917
[TBL] [Abstract][Full Text] [Related]
5. High-throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype-specific serologically relevant biomarkers.
Terkelsen T; Pernemalm M; Gromov P; Børresen-Dale AL; Krogh A; Haakensen VD; Lethiö J; Papaleo E; Gromova I
Mol Oncol; 2021 Feb; 15(2):429-461. PubMed ID: 33176066
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry.
Kurono S; Kaneko Y; Matsuura N; Oishi H; Noguchi S; Kim SJ; Tamaki Y; Aikawa T; Kotsuma Y; Inaji H; Matsuura S
Proteomics Clin Appl; 2016 May; 10(5):605-13. PubMed ID: 26970563
[TBL] [Abstract][Full Text] [Related]
8. Identification of protein clusters predictive of response to chemotherapy in breast cancer patients.
Cortesi L; Barchetti A; De Matteis E; Rossi E; Della Casa L; Marcheselli L; Tazzioli G; Lazzaretti MG; Ficarra G; Federico M; Iannone A
J Proteome Res; 2009 Nov; 8(11):4916-33. PubMed ID: 19739612
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid.
Alexander H; Stegner AL; Wagner-Mann C; Du Bois GC; Alexander S; Sauter ER
Clin Cancer Res; 2004 Nov; 10(22):7500-10. PubMed ID: 15569980
[TBL] [Abstract][Full Text] [Related]
10. Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer.
Halvorsen AR; Helland Å; Gromov P; Wielenga VT; Talman MM; Brunner N; Sandhu V; Børresen-Dale AL; Gromova I; Haakensen VD
Mol Oncol; 2017 Feb; 11(2):220-234. PubMed ID: 28145100
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of non-small cell lung cancer tissue interstitial fluids.
Li S; Wang R; Zhang M; Wang L; Cheng S
World J Surg Oncol; 2013 Aug; 11():173. PubMed ID: 23914992
[TBL] [Abstract][Full Text] [Related]
12. Calreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses.
Kabbage M; Trimeche M; Bergaoui S; Hammann P; Kuhn L; Hamrita B; ben Nasr H; Chaieb A; Chouchane L; Chahed K
Tumour Biol; 2013 Apr; 34(2):1177-88. PubMed ID: 23334957
[TBL] [Abstract][Full Text] [Related]
13. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma.
Bernhard OK; Greening DW; Barnes TW; Ji H; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2372-9. PubMed ID: 23557862
[TBL] [Abstract][Full Text] [Related]
14. Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.
Moreira JM; Cabezón T; Gromova I; Gromov P; Timmermans-Wielenga V; Machado I; Llombart-Bosch A; Kroman N; Rank F; Celis JE
Mol Oncol; 2010 Dec; 4(6):539-61. PubMed ID: 21036680
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.
Cabezón T; Gromova I; Gromov P; Serizawa R; Timmermans Wielenga V; Kroman N; Celis JE; Moreira JM
Mol Cell Proteomics; 2013 Feb; 12(2):381-94. PubMed ID: 23172894
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Tumor Secretome from Tumor Interstitial Fluid (TIF).
Gromov P; Gromova I
Methods Mol Biol; 2016; 1459():231-47. PubMed ID: 27665563
[TBL] [Abstract][Full Text] [Related]
17. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
[TBL] [Abstract][Full Text] [Related]
18. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
[TBL] [Abstract][Full Text] [Related]
19. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast.
Somiari RI; Sullivan A; Russell S; Somiari S; Hu H; Jordan R; George A; Katenhusen R; Buchowiecka A; Arciero C; Brzeski H; Hooke J; Shriver C
Proteomics; 2003 Oct; 3(10):1863-73. PubMed ID: 14625848
[TBL] [Abstract][Full Text] [Related]
20. N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome.
Terkelsen T; Haakensen VD; Saldova R; Gromov P; Hansen MK; Stöckmann H; Lingjaerde OC; Børresen-Dale AL; Papaleo E; Helland Å; Rudd PM; Gromova I
Mol Oncol; 2018 Jun; 12(6):972-990. PubMed ID: 29698574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]